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Abstract 
Background: Crataegus mexicana, Hyptis albida, Larrea tridentata, Ocimum baislicum, Prunus serotina, and Smilax spp. are used in Mexican 
traditional medicine to treat respiratory and gastrointestinal diseases such as flu, cough, diarrhea, dysentery, and other parasitic or microbial 
infections. Therefore this study was aimed at the pharmacological prospection of these plants against eleven bacterial species and three 
amitochondrial protist pathogens. 
Material and methods: The fruits or aerial parts of C. mexicana, H. albida, L. tridentata, O. baislicum, P. serotina, and Smilax spp. were 
extracted with different solvents. The antibacterial properties of organic and aqueous extracts of these plants were determined by the 
microdilution method and the microplate alamar blue assay against Stenotrophomonas maltophilia, Escherichia coli, Acinetobacter baumannii, 
Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter cloacae, Staphylococcus aureus, methicillin-resistant S. aureus, Listeria 
monocytogenes, Enterococcus faecalis, and Mycobacterium tuberculosis, whereas anti-protozoal activities of extracts were evaluated by a vial 
micro-assay against strains of Entamoeba histolytica, Trichomonas vaginalis, and Giardia lamblia. 
Results: H. albida, Smilax spp, and C. mexicana showed good activity against the Gram-positive strains, S. aureus, methicillin-resistant S. 
aureus, and E. faecalis. Four extracts (C. mexicana, H. albida, O. basilicum, and L. tridentata) showed good activity against E. histolytica, T. 
vaginalis, and G. lamblia.  
Conclusion: The extracts of these six medicinal plants could be a source for new antibacterial and antiprotozoal drugs. For this reason they are 
currently under investigation to isolate and characterize their active compounds. 
 
Keywords: antibacterial, antiprotozoal, extract, plants, traditional medicine 
 
Introduction 
Among microbial diseases, bacterial and protozoan infections have become two of the major health problems for humans over the last 
decades, mainly in low-income countries. On one hand, there is an increase in the number of drug-resistant bacteria and a dearth of novel classes 
of antibiotics (Laxminarayan et al., 2013); on the other hand, there is an increase in the number of parasitic infections in developing countries due 
to low-income rates and poor sanitation levels (Norhayati et al., 2003). Thus, microbial infections have motivated the public and private sectors to 
develop novel antibacterial and antiprotozoal agents.  
Some community and hospital-acquired bacterial infections have become untreatable with available antibiotics. Particularly, penicillin-
treated staphylococci have turned into virulent strains within a year. Methicilllin-resistant Staphylococcus aureus spurred the development of 
vancomycin-resistant strains, and Mycobacterium tuberculosis has also evolved into multidrug-resistant and extensively drug-resistant strains 
(Overbye and Barret, 2005). The most common resistant pathogens are penicillin-resistant Streptococcus pneumoniae, methicillin-resistant S. 
aureus (MRSA), vancomycin-resistant Enterococcus faecium, Salmonella typhimurium, Pseudomona aeruginosa, Klebsiella pneumoniae, 
Escherichia coli, Enterobacter spp. and Acinetobacter baumannii (Coates et al., 2002; Walsh, 2003). Current concern about resistance has 
prompted researchers to deal with a dearth of novel classes of antibacterial agents over the last two decades (Moir et al., 2012; Taylor, 2013). 
Natural products or their derivatives have played a critical role in the discovery and development of different classes of antibiotics, but the 
innovative antibiotic pipeline has decreased since the 1970s (Fernandes, 2006; Butler et al., 2013). Current clinical antibacterial agents exhibit 
structural similarities that make them more susceptible to bacteria resistance mechanisms. Therefore, the quest for new antibacterial agents should 
be directed to the discovery of structurally diverse compounds from natural sources other than microorganisms and targets other than those of 
commercial drugs (Taylor, 2013). 
In addition to the problem of bacterial resistance, parasitic infections have also drawn the attention of researchers, particularly 
amoebiasis, trichomoniasis, and giardiasis, which are caused by the amitochondrial protist pathogens Entamoeba histolytica, Trichomonas 
vaginalis, and Giardia lamblia, respectively (Schwebke and Burgess, 2004; Stanley, 2003; Lujan, 2006). The enteric pathogens G. lamblia and E. 
histolytica cause persistent diarrhea, dysentery, stomach pain, cramps, bloating, and tenderness. According to the World Health Organization, 
amoebiasis is the third leading cause of death due to parasitic infections, surpassed only by malaria and schistosomiasis (WHO, 1997). Giardiasis 
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mainly affects children under 5 years of age in developing countries, contributing to 2.5 million deaths annually from diarrheal disease (Ricci et 
al., 2006). On the other hand, trichomoniasis, a sexually transmitted disease associated with vaginitis, cervicitis, urethritis, prostatitis, 
epididymitis, cervical cancer, and infertility, accounts for 180 million infections acquired annually worldwide (Ali and Nosaki, 2007; Nanda et al., 
2006).  
E. histolytica, T. vaginalis, and G. lamblia infections are mainly treated with imidazole type drugs, but it has been reported that these 
three protist pathogens have developed drug resistance (Upcroft and Upcroft, 2001; Pal et al., 2009). This has produced an urgent need for more 
efficient and safer antiprotozoal agents. The development of new antiparasitic drugs has not been a priority for the pharmaceutical industry 
because many parasitic diseases occur in developing countries where the population cannot afford to pay for the drugs. Thus an investment in 
drug development against parasitosis is a risky affair (Wink, 2012).  
In the continuous search for novel classes of antibacterial and antiprotozoal agents from plants (Favela-Hernández et al., 2012; Rojas et 
al., 1992; Bocanegra-García et al., 2009; González-Garza et al., 1989; Mata-Cárdenas et al.,, 2008), we would like to describe the antibacterial 
and antiprotozoal evaluation of extracts obtained from six plants that are used in Mexican traditional medicine to treat respiratory and 
gastrointestinal diseases such as flu, cough, diarrhea, dysentery, and other parasitic or microbial infections (Biblioteca Digital de la Medicina 
Tradicional Mexicana, 2014).     
Crataegus mexicana Moc.Sessé, (Rosaceae) ex C. pubescens Kunth Steud., locally known as tejocote, manzanilla, tejocotera, 
manzanillo, and karash, among other names, is a Mexican medicinal plant traditionally used as an antihypertensive and cardiotonic drug. The 
infusions of its leaves and bark are also used to treat diarrhea, “stomach pain”, and to fight against parasitic worms as well as amoebas that cause 
dysentery. It has also been reported that it is traditionally used for the treatment of several respiratory diseases such as flu, cough, and asthma 
(Biblioteca Digital de la Medicina Tradicional Mexicana, 2014). The tracheal relaxant effect of the leaves of C. mexicana has been investigated 
using isolated tracheal rings of guinea-pig as an experimental model (Arrieta et al., 2010). At the clinical level, standardized extracts of pure 
Crataegus species, such as C. pinnatifida and C. oxyacantha, and other highly hybridized species, are currently in use for the treatment of 
congestive heart failure and hypertension (Koch and Malek, 2011). According to literature, no chemical studies have been reported for C. 
mexicana (Edwards et al., 2012). 
Hyptis albida Kunth (Lamiaceae), generally known as "salvia blanca", has been used traditionally to treat influenza and rheumatic pain 
as well as for the healing of wounds and as an anthelmintic (Biblioteca Digital de la Medicina Tradicional Mexicana, 2014; Rojas et al., 1992; 
Pereda-Miranda et al., 1990a). The leaves are also reputed to act as a potent insect repellent (Altschul, 1973). Three triterpene lactones, four 
triterpenes, and five flavonoids have been isolated from the acetone extract of H. albida (Pereda-Miranda, 1990a). The anti-inflammatory effects 
of the chloroform extract of this plant on lipopolysaccharide-stimulated peritoneal macrophages have been described (Sánchez-Miranda et al., 
2013). 
              Larrea tridentata (Sesse & Mocino ex DC.) Coville is also known as Larrea, chaparral, or creosote bush in the United States and 
gobernadora (governess) and hediondilla (little smelly one) in Mexico. It is a shrubby plant belonging to the family Zygophyllaceae, which 
dominates some areas of the southwest desert in the United States and Northern Mexico, as well as some desert areas of Argentina (Abou-Gazar 
et al., 2004; Arteaga et al., 2005). It is traditionally used in Mexico to treat infections, kidney problems, gallstones, diabetes, rheumatism, arthritis, 
wounds, skin injuries, and dissolve tumors.  In the United States it is used to treat tuberculosis, venereal diseases, cancer, and wounds, as well as 
an expectorant and tonic (Ross, 2005). It has been reported that L. tridentata possesses antibacterial lignans and flavonoids (Favela-Hernández et 
al., 2012), cytotoxic lignans (Yokosuda et al., 2011; Lambert et al., 2005), cytotoxic triterpene glycosides (Jitsuno and Mimaki, 2010), antioxidant 
lignans (Abou-Gazar et al., 2004), anti-HIV lignans (Gnabre et al., 1996), furanoid lignans (Konno et al.  1990), and flavonoids (Chirikdjian, 
1974; Bernhard and Thiele, 1981). The methanolic extract of L. tridentata has activity against several nosocomial bacteria (Bocanegra-García et 
al., 2009). 
Ocimum basilicum is commonly known as basil or albácar. It is a culinary plant belonging to the Lamiaceae family that is extensively 
used as a flavoring agent in a wide variety of regions and as a popular traditional folk remedy. This plant is used as carminative, stimulant, 
diaphoretic, diuretic, dyspeptic, antiseptic, anesthetic, flatulence, gastritis, anti-spasmodic, anthelmintic, anti-diarrheal, analgesic and anti-tussive. 
Other medicinal uses of O. basilicum include treatment of some gastrointestinal disorders, gastrodynia, diarrhea and vomiting (Biblioteca Digital 
de la Medicina Tradicional Mexicana, 2014; Shirazi et al., 2014). The essential oil has antioxidant, antimicrobial, cytotoxic and larvicidal 
properties (Shirazi et al., 2014; Kuorwel et al., 2011; Govindarajan et al., 2013).  Chemical composition of the essential oil of O. basilicum 
includes methylchavicol, neral, nerol, geranial, 1,8-cineole, linalool, citral, estragole, eugenol, methylcinnamate, camphor, ocimene, geraniol, 
bisabolene, caryophyllene, and methyleugenol (Shirazi et al., 2014; Kuorwel et al., 2011; Govindarajan et al., 2013; Miele et al., 2000; de 
Vincenzi et al., 2000). It was also reported that O. basilicum contains three new compounds named basilol, ocimol, and basilimoside (Siddiqui et 
al., 2007).  
Prunus serotina (Cav. ex Spreng) McVaugh (Rosaceae) is a 60 to 90 foot-tall native North American tree, which is widely distributed in 
Mexico and commonly called “capulín”, “taunday”, “tzuúri”, “chencua”, American black cherry, and bird cherry (Martínez, 1991). Some people 
from Mexico have used the bark, leaves, inflorescences and fruits of P. serotina for healing cardiac, pulmonary, and intestinal ailments; 
particularly, the fruits are used, alone or prepared in syrups and liquors, for the treatment of cough and diarrhea (Biblioteca Digital de la Medicina 
Tradicional Mexicana, 2014; Argueta, 1994a). Besides their use in traditional medicine, the fruits of this plant are also part of the traditional 
Mexican diet and are consumed fresh, dried, as an ingredient of “tamales” or prepared in jam. P. serotina has also been the subject of a few 
chemical studies. Kaempferol, quercetin and isorhamnetin glycosides, ursolic acid derivatives and prunasin have been detected in the leaves 
(Biessels et al., 1974; Olszewska, 2005a, b). Cyanogenic glycosides such as amygdalin and prunasin have been isolated from the seeds 
(Santamour, 1998), whereas anthocyanidins have been detected in the fruit skin (Ordaz-Galindo, 1999). Previous studies carried out by our 
research group demonstrated that the lyophilized aqueous and methanolic extracts obtained from black cherry leaves promoted vascular smooth 
muscle relaxation of the rat aorta (Ibarra-Alvarado et al., 2010).  A bioactivity-directed chemical study of the methanolic extract of black cherry 
leaves led to the isolation of three known natural products: hyperoside, prunine, and ursolic acid, which elicited a concentration-dependent 
relaxation of vascular muscle (Ibarra-Alvarado et al., 2009).  
The commercial root product of Cocolmeca is used in Mexican traditional medicine to treat obesity, syphilis, parasites, dysentery, and 
diabetes (Biblioteca Digital de la Medicina Tradicional Mexicana, 2014; Argueta et al., 1994b). Cocolmeca is referenced in the literature as 
Smilax spp. (Smilacaceae), but it is also named Smilax cordifolia, S. acutifolia, S. invenusta, and S. schiedeana (Martínez, 1979). Species of 
Smilax are widely distributed from Asia to America and several species have been used as traditional remedies to ameliorate infectious diseases 
(Challinor et al., 2012; Kuo et al., 2005; Seo et al., 2012; Hooda et al., 2011; Xu et al., 2013). S. glauca, S. rotundifolia, and S. china have been 
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traditionally used in China to treat syphilis, leprosy, and psoriasis (Challinor et al., 2012; Kuo et al., 2005; Seo et al., 2012). In Ayurveda, S. 
zeylanica is reported for the treatment of syphilis, gonorrhea, and skin diseases (Hooda et al., 2011). Pharmacological prospection of several 
species of Smilax have reported that S. glabra possesses anti-inflammatory, immunomodulatory, antitumor, and antimicrobial effects (Xu et al., 
2013). The chemical constituents of several Smilax species have been reported to be triterpenoid and steroidal saponins (sarsaparrilloside, 
parillin), steroidal sapogenins (smilagenin, sarsapogenin), stilbenes (resveratrol), flavonoids [astilbin, (2S,3S)-5-O-β-D-glucopyranosiloxy-6-
methyl-3’-methoxy-3,7,4’-trihydroxyflavone, (2S,3S)-5-O-β-D-glucopyranosiloxy-6-methyl-4’-methoxy-3,7,3’-trihydroxyflavone)], 
triterpenoids, phenylpropanoid glycosides (smilasides D, E, and F), epicatechins, etc. (Challinor et al., 2012; Kuo et al., 2005; Seo et al., 2012; 
Hooda et al., 2011; Xu et al., 2013). 
The selected species are among the most used plants in Mexican traditional medicine. These plants are used in respiratory and 
gastrointestinal diseases that are related to antimicrobial and antiparasitic activities (Biblioteca Digital de la Medicina Tradicional Mexicana, 
2014). Therefore, we decided to evaluate antibacterial and antiprotozoal effects of their extracts, because these plants could be a source of new 
antibacterial and antiprotozoal drugs. 
 
 
Materials and Methods 
Sample collection 
 
Leaves and fruits of C. mexicana were collected on October 31, 2010, in Laguna de Servín, Amealco, Querétaro. A voucher specimen 
(A. Cabrera 2560) has been deposited at the herbarium Jerzy Rzedowski (HJR), Faculty of Natural Sciences, Universidad Autónoma de Querétaro. 
The fruits of P. serotina were obtained from orchards in Huejotzingo, Puebla (México) in May, 2011, and were transported to Querétaro and 
stored at -70°C. A voucher specimen (825) was identified by Dr. M. Martínez and Dr. L. Hernández-Sandoval and deposited in the HJR. The 
aerial parts of H. albida were collected in Guadalcazar, in the state of San Luis Potosí, México, in July 2009. This plant was identified by the 
taxonomist José García Pérez and a voucher specimen (SPLM20419) has been deposited in the Isidro Palacios herbarium of the Universidad 
Autónoma de San Luis Potosí. The leaves of L. tridentata were collected in Nuevo León, México in July, 2009. A voucher specimen (024772) 
was identified by the biologist Mauricio González Ferrara and deposited in the herbarium of the Facultad de Ciencias Biológicas (FCB), 
Universidad Autónoma de Nuevo León, Mexico. The aerial parts of O. basilicum were collected in San Nicolás de los Garza, Nuevo León, 
Mexico. In November, 2012 and a voucher sample (010293) was placed in the herbarium of the FCB. Finally, Dr. Carmelita García Padrón 
provided the roots of Smilax spp. in January, 2011. Dr. Carmelita is the owner of Nature Select Company located at Carpinteros de Paracho 416-
A, Colonia Vasco de Quiroga, Morelia, Michoacán, Mexico.  
 
Plant extract preparation 
 
The freeze-dried fruits of C. mexicana were extracted separately by maceration (100 g) and decoction (100 g) with water and 
the shade-dried leaves (100 g) successively by maceration with hexane (500 ml), CH2Cl2 (500 ml), and CH3OH (500 ml). Each extract was 
filtered separately, and the organic solvents were removed in a rotary evaporator at reduced pressure. Aqueous extracts were freeze-
dried. The fruits of P. serotina were peeled to separate flesh and peel and both were lyophilized separately. Lyophilized peel and flesh were 
extracted with CH2Cl2/CH3OH (1:1) by maceration and solvent was evaporated under reduced pressure. The shade-dried aerial parts of H. albida 
and O. basilicum, as well as the leaves of L. tridentata, and the roots of Smilax spp, were ground separately. Each powdered material (100 g) was 
macerated with 500 ml of CH2Cl2/CH3OH (1:1). Each extract was filtered separately, and the solvents were removed in a rotary evaporator at 
reduced pressure; the dry extracts were then stored at 4 °C until use. 
 
Biological assays  
Sample preparation 
 
Stock solutions for antibacterial activity were prepared by dissolving approximately 1 mg of each extract with dimethyl sulfoxide 
(DMSO) to achieve a concentration of 20 mg/ml. Stock solutions were kept at -20 °C until their use. Antibacterial working solutions were 
prepared from an aliquot of each of the stocks and diluted with Mueller-Hinton medium. The same procedure was used to prepare anti-tubercular 
working solutions, but using Middelbrook 7H9 medium supplemented with OADC instead. Stock solutions for antiprotozoal activity were 
prepared dissolving each extract and metronidazole in dimethyl sulfoxide (DMSO) to achieve a concentration of 1 mg/ml. All stock solutions 
were stored at -20 °C until use.  
 
Bacterial strains and inoculum preparation 
 
For antibacterial activity, the following strains were used: Gram-negative bacteria: Stenotrophomonas maltophilia ATCC 12714, 
Escherichia coli ATCC 25922, Acinetobacter baumannii ATCC 15308, Pseudomonas aeruginosa ATCC 27853, Klebsiella pneumoniae ATCC 
700603 and Enterobacter cloacae ATCC 35030; Gram-positive bacteria: Staphylococcus aureus ATCC29213, methicillin-resistant 
Staphylococcus aureus MRSA ATCC BAA-44, Listeria monocytogenes ATCC 19111 and Enterococcus faecalis ATCC 29212. Strains were 
inoculated into plates prepared with 5% blood agar grown for 24 hours at 37 °C. To prepare inoculum for testing, three to five colonies of each 
culture were transferred into tubes with sterile saline, and turbidity was adjusted to 0.5 McFarland standard (1.5 X 108 CFU/ml).  
Subsequently, 10 l were transferred into 11 ml Mueller-Hinton broth to achieve 5 x 105 CFU/ml. For anti-tubercular activity, M. 
tuberculosis H37Rv American Type Culture Collection (ATCC 27294) sensitive to isoniazid, rifampicin, ethambutol and pyrizanamide was used. 
Mycobacteria was cultured in Middlebrook 7H9 broth supplemented with 0.2% glycerol and 10% OADC (oleic acid albumin dextrose catalase, 
Becton, Dickinson and Company, Franklin Lakes, NJ) at 37 °C for 2 weeks in order to reach logarithmic phase growth. Testing inoculum was 
prepared diluting the bacterial suspension with culture medium to adjust turbidity to McFarland’s nephelometer No. 1 standard; this bacterial 
suspension was further diluted to 1:20 with the same culture medium. The Minimum Inhibitory Concentration (MIC) was determined as the 
lowest concentration of drug that inhibited the growth of bacteria. 
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Protozoa cultures  
E. histolytica strain HM-1:IMSS, T. vaginalis strain GT-13, and G. lamblia strain 0989:IMSS were used in this study. E. histolytica and 
T. vaginalis were grown in PEHPS medium (Said-Fernández et al., 1988), and G. lamblia in TYI-S-33 supplemented with bile (Keister, 1983). 
All three species were subcultured three times each week. Parasites used in the assays to determine drug susceptibility were harvested when 
cultures had reached the middle of their respective logarithmic growth phase (Mata-Cárdenas et al., 2008).  
 
Antibacterial activity 
 
                Antibacterial activity was determined by the microdilution method (Zgoda and Porter 2001). All tests were performed twice in different 
days. Levofloxacin and media with bacteria without sample were used as positive and negative controls, respectively.  
 
Antitubercular activity  
 
Antitubercular activity was determined by Alamar Blue assay microplate (Camacho-Corona et al., 2009). Each experiment was 
performed twice on different days. Isoniazid and media with bacteria without sample were used as positive and negative controls, respectively.   
 
Antiprotozoal activity 
 
Antiprotozoal activity was determined as previously described in the literature (Mata-Cárdenas et al., 1996). Each drug was assayed in 
triplicate with each protozoan species and the mean and 95% confidence limits were calculated. The Medium Inhibitory Concentration (IC50) was 
calculated using the Probit program. Metronidazol and protozoa with medium without sample were used as positive and negative controls, 
respectively. 
 
 
Results  
Antibacterial activity 
 
Nine organic extracts and one lyophilized sample obtained from different parts of five plant species (C. mexicana, H. albida, O. 
basilicum, P. serotina, and Smilax spp.) were screened against Gram-positive, Gram-negative bacterial strains and acid-alcohol bacilli M. 
tuberculosis H37Rv, the MIC values are shown in Table 1. Of the 10 samples tested against 11 bacteria strains, only three exhibited good activity 
against three pathogens: S. aureus, methicillin-resistant S. aureus, and E. faecalis. The best activity was observed for extracts of the aerial parts of 
H. albida and the roots of Smilax spp., which exhibited MIC values of 25, 25 and 50 g/ml against three Gram-positive strains: S. aureus, 
methicillin-resistant S. aureus, and E. faecalis, respectively. Furthermore, the organic extracts of H. albida and Smilax spp  showed moderated to 
weak activity towards E. coli (MIC 100-200 g/mL), K. pneumoniae (MIC 100 g/mL), L. monocytogenes (MIC 200 g/mL), and M. 
tuberculosis H37Rv (MIC 200 g/mL).  
The aforementioned three Gram-positive bacteria were also inhibited by the methanolic extract of C. mexicana leaves with MIC values 
of 50 g/ml against S. aureus and E. faecalis and 100 g/ml towards methicillin-resistant S. aureus (Table 1).  In addition, the methanolic extract 
of C. mexicana leaves displayed activity against S. maltophilia (MIC 50 g/ml), A. baumannii (MIC 200 g/ml), K. pneumoniae (MIC 200 
g/ml), and M. tuberculosis H37Rv (MIC 100 g/ml) 
Other extracts that showed weak activity (MIC 200 g/ml) were the aqueous extracts of P. serotina (A. baumannii), the organic extract of P. 
serotina (S. maltophilia, methicillin-resistant S. aureus, M. tuberculosis), cloroformic extract of C. mexicana leaves (L. monocytogenes), hexanic 
extract of C. mexicana leaves (P. aeruginosa, L. monocytogenes, M. tuberculosis), methanolic extract of C. mexicana fruits (S. aureus), and 
CH2Cl2 extract of C. mexicana fruits (E. coli). 
 
Antiprotozoal activity 
 
Ten organic extracts and one lyophilized sample obtained from different parts of six plants (C. mexicana, H. albida, O. baislicum, P. 
serotina, L. tridentata, and Smilax spp.) were screened against E. histolytica, T. vaginalis, and G. lamblia. The IC50 values are shown in Table 2. 
The organic extracts of C. mexicana leaves, H. albida, O. basilicum, and L. tridentata were active against the tested parasites. The extract of H. 
albida was the most active against G. lamblia and T. vaginalis and exhibited IC50 values of 16.11 and 11.42 µg/ml, respectively (Table 2).  
The methanolic extract of C. mexicana leaves exhibited moderate activity against G. lamblia (IC50 = 153 g/ml) and T. vaginalis (IC50 = 
125 g/ml). The extract of O. basilicum also showed moderate activity against G. lamblia (IC50 = 100 g/ml). Finally, the extract of L. tridentata 
exhibited moderate inhibitory activity against E. histolytica (IC50 = 100 g/ml), G. lamblia (IC50 = 116 g/ml) and T. vaginalis (IC50 = 118 g/ml).  
 
 
Discussion 
Antibacterial activity 
 
Results of antibacterial activity show that three extracts have a wide range of antibacterial activity. These are obtained from H. albida, 
Smilax spp and C. mexicana (Table 1). Of particular interest is the good inhibitory activity of Smilax spp, against methicillin-resistant strains of S. 
aureus, suggesting that this organic extract probably contains novel antibacterial compounds useful for the treatment of resistant staphylococcal 
infections. This suggestion could be reinforced with previous reports that describe the potent antibacterial activity of two taxonomically related 
species, S. china and S. glabra (Seo et al., 2012; Xu et al., 2013). One of the aforementioned studies reported two epicatechins (smiglabrone A 
and cinchonain Ib), two stilbenes (smiglastilbene and trans-resveratrol) and two flavanones (smilachromanone and sakuranetin) as the most 
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bioactive molecules against S. aureus, methicillin-resistant S. aureus, and E. faecalis, all having MICs in the range of 0.08-1.05 mM (Xu et al., 
2013).  
 
 
 
Table 1: Antibacterial activity of plant extracts 
Bacteria/Samples  Minimum Inhibitory Concentration (MIC, µg/mL) 
1 2 3 4 5 6 7 8 9 10 11 
Stenotrophomonas maltophilia 
ATCC 12714 
200 200 50 200 200 200 200 200 200 200 4 
Escherichia coli 
ATCC 25922 
200 200 200 200 200 200 200 200 100 200 0.78 
Acinetobacter baumannii 
ATCC 15308 
200 200 200 200 200 200 200 200 200 200 4 
Pseudomona aeruginosa 
ATCC 27853 
200 200 200 200 200 200 200 200 200 200 4 
Enterobacter cloacae 
ATCC 35030 
200 200 200 200 200 200 200 200 200 200 0.78 
Klebsiella pneumoniae 
ATCC 700603 
200 200 200 200 200 200 200 100 100 200 4 
Staphylococcus aureus 
ATCC29213 
200 200 50 200 200 200 200 25 25 200 6.25 
Staphylococcus aureus 
MRSA ATCC BAA-44 
200 200 100 200 200 200 200 25 25 200 6.25 
Listeria monocytogenes 
ATCC 19111 
200 200 200 200 200 200 200 200 200 200 2 
Enterococcus faecalis 
ATCC 29212.   
200 200 50 200 200 200 200 50 50 200 0.78 
Mycobacterium tuberculosis  
H37Rv 
200 200 100 200 200 200 200 200 200 200 0.02 
 
 
Plant extracts were screened for antibacterial activity. Samples: 1.- Prunus serotina (lyophilized flesh and peel fruits). 2.- P. serotina 
(flesh and peel, CH2Cl2/CH3OH 1:1). 3.- Crategus mexicana (leaves, CH3OH). 4.- C. mexicana (leaves, CH2Cl2). 5.- C. mexicana (leaves, C6H12). 
6.- C. mexicana (fruits, H2O, maceration). 7.- C. mexicana (fruits, H2O, decoction). 8.- Hyptis albida (aerial parts, CH2Cl2/CH3OH 1:1). 9.- 
Smilax spp. (roots, CH2Cl2:CH3OH 1:1). 10.- Ocimum basilicum (aerial parts, CH2Cl2/CH3OH 1:1).  11.- Levofloxacin (antibacterial) and 
isoniazid (antitubercular). 
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Table 2: Antiprotozoal activity (IC50 in g/ml) of plant extracts 
Samples Entamoeba histolytica Giardia lamblia Trichomonas vaginalis 
1 > 300 >300 >300 
2 > 300 >300 >300 
3 > 300 153 125 
4 > 300 > 300 > 300 
5 > 300 > 300 > 300 
6 > 300 > 300 > 300 
7 > 300 > 300 > 300 
8 > 300 16.11 11.42 
9 255 > 300 > 300 
10 > 300 100.31 > 300 
11 100 116 118 
Metronidazole 0.711 0.512 1.04 
Plant extracts were screened for antiprotozoal activity. Samples: 1.- Prunus serotina (lyophilized flesh and peel fruits). 2.- P. serotina (flesh and 
peel, CH2Cl2/CH3OH 1:1). 3.- Crategus mexicana (leaves, CH3OH). 4.- C. mexicana (leaves, CH2Cl2). 5.- C. mexicana (leaves, C6H12). 6.- C. 
mexicana (fruits, maceration). 7.- C. mexicana (fruits, decoction). 8.- Hyptis albida (aerial parts, CH2Cl2/CH3OH 1:1). 9.- Smilax spp. (roots, 
CH2Cl2:CH3OH 1:1). 10.- Ocimum basilicum (aerial parts, CH2Cl2/CH3OH 1:1). 11.- Larrea tridentata (leaves, CH2Cl2/CH3OH 1:1 ) 
 
Previous research reported two flavonoids from H. albida (cirsimaritin and isosakuranetin), both active against S. aureus with MIC 
values of 31.25 and 50 g/ml, respectively (Rojas et al., 1992). H. albida has ursolic, betulinic, and oleanolic acids (Pereda-Miranda et al., 
1990b), which inhibit S. aureus (ursolic acid, MIC = 8g/ml; betulinic acid, MIC = 64 g/ml; oleanolic acid, MIC = 32g/ml) and E. faecalis 
(ursolic and oleanolic acids, MIC = 4 and 8 g/ml, respectively) (Fontanay et al., 2008; Chung et al., 2014). Despite these reports, our current 
research is focused on the isolation of different molecules responsible for the inhibitory properties of H. albida against sensitive and methicillin-
resistant S. aureus and E. faecalis.  
The methanolic extract obtained from leaves of C. mexicana is currently under investigation in order to isolate and characterize the 
active antibacterial compounds and to provide the first report on the chemistry of this plant. 
 
Antiprotozoal activity 
 
Results of antiprotozoal activity showed that the extract of H. albida was the most active against G. lamblia and T. vaginalis (Table 2). 
It is important to point out that there are no reports on the antiprotozoal activity of this plant and further studies should be done in order to isolate 
its active antiprotozoal compounds.  
The methanolic extract of C. mexicana leaves exhibited moderate activity against G. lamblia and T. vaginalis (Table 2), which could 
explain in part the traditional use of its leaves and bark against dysentery caused by amoebas (Biblioteca Digital de la Medicina Tradicional 
Mexicana, 2014). In view of the antiprotozoal activity of C. mexicana, further research should be conducted to characterize its bioactive 
molecules. 
The extract of O. basilicum showed moderate activity against G. lamblia (Table 2), which supports its use in traditional medicine to 
treat gastrointestinal disorders (Shirazi et al., 2014). Recently, the essential oil of O. basilicum and two of its main components (linalool and 
eugenol) were reported to inhibit the growth of G. lamblia in vitro (Almeida et al., 2007). However, the present research gives evidence of the 
anti-giardial activity exhibited by the organic extract obtained from the aerial parts of O. basilicum, which could be attributed to its polar 
compounds, thus current research is aimed at the isolation of its bioactive molecules. 
Finally, the extract of L. tridentata exhibited inhibitory activity against E. histolytica,  G. lamblia and T. vaginalis (Table 2). A previous 
report on L. tridentata demonstrated that one of its compounds, nordihydroguairetic acid, inhibited the growth of E. invadens (Segura, 1978). That 
research allowed us to suggest that the antiprotozoal activity of L. tridentata in our study could be attributed to one or more of its lignans and 
flavonoids previously isolated by our research group (Favela-Hernández et al., 2012). Therefore, further work should be carried out to test the 
antiprotozoal activity of the isolates in the search for new agents against these protist pathogens.  
 
Conclusions 
 
Organic extracts obtained from H. albida, Smilax spp., and C. mexicana exhibited good activity against three Gram-positive strains, S. 
aureus, methicillin-resistant S. aureus, and E. faecalis, with MIC values of 25, 50, and 100 g/ml. These crude extracts are currently under 
investigation in order to isolate, characterize, and determine the antibacterial properties of their chemical constituents. According to the 
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antiprotozoal properties of crude extracts, H. albida exhibited potent activity against G. lamblia and T. vaginalis with IC50 values of 16.11 and 
11.42 µg/ml, while the methanolic extracts of C. mexicana, O. basilicum, and L. tridentata showed moderate activity against the three 
amitochondrial parasites with IC50 values over 100 µg/ml. Among these plants, H. albida is the most attractive source to discover new 
antiprotozoal agents and is now under investigation. 
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